Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Total Debt: 2020-2023

Historic Total Debt for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to $97,707.

  • ADC Therapeutics' Total Debt rose 1.01% to $97,707 in Q3 2023 from the same period last year, while for Sep 2023 it was $122.5 million, marking a year-over-year decrease of 57.06%. This contributed to the annual value of $122.2 million for FY2022, which is 30.36% up from last year.
  • Latest data reveals that ADC Therapeutics reported Total Debt of $97,707 as of Q3 2023, which was up 0.36% from $97,356 recorded in Q2 2023.
  • ADC Therapeutics' Total Debt's 5-year high stood at $122.2 million during Q4 2022, with a 5-year trough of $35,968 in Q2 2020.
  • For the 3-year period, ADC Therapeutics' Total Debt averaged around $57.3 million, with its median value being $90.8 million (2021).
  • Its Total Debt has fluctuated over the past 5 years, first skyrocketed by 253,679.85% in 2021, then tumbled by 99.90% in 2023.
  • Over the past 4 years, ADC Therapeutics' Total Debt (Quarterly) stood at $36,430 in 2020, then surged by 253,679.85% to $93.7 million in 2021, then skyrocketed by 30.36% to $122.2 million in 2022, then increased by 1.01% to $97,707 in 2023.
  • Its Total Debt stands at $97,707 for Q3 2023, versus $97,356 for Q2 2023 and $97,011 for Q1 2023.